文献速递细菌感染、耐药与抗菌药物医院感染防控

个体化抗生素方案作为质量改进举措以减少独立儿童医院造血细胞移植患者的碳青霉烯类使用

Individualized Antibiotic Plans as a Quality Improvement Initiative to Reduce Carbapenem Use for Hematopoietic Cell Transplant Patients at a Freestanding Pediatric Hospital.
PubMed 文献 · Clin Infect Dis · 2024-01-01

在独立儿童医院造血细胞移植患者中实施个体化抗生素方案(IAP),提供移植前中性粒细胞减少预防、发热性中性粒细胞减少经验性治疗及血流动力学不稳定经验性治疗的推荐。比较实施前后两个3年期间每月每1000患者日的抗生素治疗天数,结果显示总体抗生素使用减少(每月减少19.6 DOT/1000患者日;P=0.004),碳青霉烯类持续下降,血流感染和艰难梭菌检测阳性率无变化,超过90%的提供者认为IAP非常有价值。

要点

  • IAP实施后总体抗生素使用每月减少19.6 DOT/1000患者日(P=0.004)。
  • 碳青霉烯类使用在IAP实施后持续下降。
  • 血流感染和艰难梭菌检测阳性率无变化,超过90%提供者认为IAP有价值。

核心结论

  • 在高风险HCT人群中实施IAP减少了总体抗生素使用,未增加血流感染率或艰难梭菌检测阳性率,且项目受到提供者欢迎。

研究设计与样本

  • 在本儿科中心开展的质量改进项目,比较实施IAP前后两个3年期间每月每1000患者日的抗生素治疗天数。
  • IAP提供移植前中性粒细胞减少预防、发热性中性粒细胞减少经验性治疗及血流动力学不稳定经验性治疗的推荐。
  • 比较队列间血流感染和艰难梭菌检测阳性率,并对提供者进行问卷调查评估使用体验。

主要发现

  • 实施IAP后总体抗生素使用减少,每月减少19.6 DOT/1000患者日(P=0.004)。
  • 碳青霉烯类使用在IAP实施后持续下降。
  • 血流感染和艰难梭菌检测阳性率无变化。
  • 超过90%的提供者认为IAP对其实践极其有价值或非常有价值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Providers must balance effective empiric therapy against toxicity risks and collateral damage when selecting antibiotic therapy for patients receiving hematopoietic cell transplant (HCT). Antimicrobial stewardship interventions during HCT are often challenging due to concern for undertreating potential infections. METHODS: In an effort to decrease unnecessary carbapenem exposure for patients undergoing HCT at our pediatric center, we implemented individualized antibiotic plans (IAPs) to provide recommendations for preengraftment neutropenia prophylaxis, empiric treatment of febrile neutropenia, and empiric treatment for hemodynamic instability. We compared monthly antibiotic days of therapy (DOT) adjusted per 1000 patient-days for carbapenems, antipseudomonal cephalosporins, and all antibiotics during two 3-year periods immediately before and after the implementation of IAPs to measure the impact of IAP on prescribing behavior. Bloodstream infection (BSIs) and Clostridioides difficile (CD) positivity test rates were also compared between cohorts. Last, providers were surveyed to assess their experience of using IAPs in antibiotic decision making. RESULTS: Overall antibiotic use decreased after the implementation of IAPs (monthly reduction of 19.6 DOT/1000 patient-days; P = .004), with carbapenems showing a continuing decline after IAP implementation. BSI and CD positivity rates were unchanged. More than 90% of providers found IAPs to be either extremely or very valuable for their practice. CONCLUSIONS: Implementation of IAPs in this high-risk HCT population led to reduction in overall antibiotic use without increase in rate of BSI or CD test positivity. The program was well received by providers.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Brothers AW, Pak DJ, Poole NM, et al. Individualized Antibiotic Plans as a Quality Improvement Initiative to Reduce Carbapenem Use for Hematopoietic Cell Transplant Patients at a Freestanding Pediatric Hospital. Clin Infect Dis. 2024. PMID: 37647637. doi:10.1093/cid/ciad518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。